Literature DB >> 21893535

Contribution of the GAVI Alliance to improving health and reducing poverty.

Julian Lob-Levyt1.   

Abstract

The Global Alliance for Vaccines and Immunization (GAVI), now 10 years old, was established as a successful and innovative public-private partnership to deal with a fundamental inequity. The poorest children in the poorest parts of the world were being denied access to life-saving vaccines simply on the basis of cost. GAVI has been successful in mobilizing significant funding from donors and through innovative financing instruments, immunizing large numbers of children. GAVI has been less successful, at least in the time frames first envisaged, at quickly reducing the prices of new and under-used vaccines to levels affordable by the poorest countries. Vaccines remain some of the most cost effective of public health interventions. As GAVI seeks to introduce a new set of vaccines to tackle major killers such as pneumonia and diarrhoea, and emerging threats such as cervical cancer, it needs to raise significant additional funds. There is no single solution. Multiple and new instruments will be required to raise finance both globally and at the country level, and also to incentivize industry and others to provide vaccines at affordable prices to the poorest countries.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21893535      PMCID: PMC3146772          DOI: 10.1098/rstb.2011.0040

Source DB:  PubMed          Journal:  Philos Trans R Soc Lond B Biol Sci        ISSN: 0962-8436            Impact factor:   6.237


  1 in total

1.  Action for child survival: elimination of Haemophilus influenzae type b meningitis in Uganda.

Authors:  Rosamund F Lewis; Annet Kisakye; Bradford D Gessner; Chaplain Duku; John Bosco Odipio; Robert Iriso; Denis Nansera; Fiona Braka; Issa Makumbi; Addy Kekitiinwa
Journal:  Bull World Health Organ       Date:  2008-04       Impact factor: 9.408

  1 in total
  10 in total

1.  Charting the evolution of approaches employed by the Global Alliance for Vaccines and Immunizations (GAVI) to address inequities in access to immunization: a systematic qualitative review of GAVI policies, strategies and resource allocation mechanisms through an equity lens (1999-2014).

Authors:  Gian Gandhi
Journal:  BMC Public Health       Date:  2015-11-30       Impact factor: 3.295

2.  Vaccines and global health.

Authors:  Brian Greenwood; David Salisbury; Adrian V S Hill
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2011-10-12       Impact factor: 6.237

3.  Protecting against pneumococcal disease: critical interactions between probiotics and the airway microbiome.

Authors:  Paul V Licciardi; Zheng Quan Toh; Eileen Dunne; Sook-San Wong; Edward K Mulholland; Mimi Tang; Roy M Robins-Browne; Catherine Satzke
Journal:  PLoS Pathog       Date:  2012-06-07       Impact factor: 6.823

4.  Epidemiology and etiology of childhood pneumonia in 2010: estimates of incidence, severe morbidity, mortality, underlying risk factors and causative pathogens for 192 countries.

Authors:  Igor Rudan; Katherine L O'Brien; Harish Nair; Li Liu; Evropi Theodoratou; Shamim Qazi; Ivana Lukšić; Christa L Fischer Walker; Robert E Black; Harry Campbell
Journal:  J Glob Health       Date:  2013-06       Impact factor: 4.413

5.  Estimating global and regional morbidity from acute bacterial meningitis in children: assessment of the evidence.

Authors:  Ivana Lukšić; Rosanda Mulić; Rachel Falconer; Mirjana Orban; Simrita Sidhu; Igor Rudan
Journal:  Croat Med J       Date:  2013-12       Impact factor: 1.351

6.  Armed conflict, a neglected determinant of childhood vaccination: some children are left behind.

Authors:  Ngo Valery Ngo; Ngambouk Vitalis Pemunta; Nyenkuna Elisabeth Muluh; Miranda Adedze; Nduma Basil; Simon Agwale
Journal:  Hum Vaccin Immunother       Date:  2019-12-06       Impact factor: 3.452

7.  Estimating the health impact of vaccination against ten pathogens in 98 low-income and middle-income countries from 2000 to 2030: a modelling study.

Authors:  Xiang Li; Christinah Mukandavire; Zulma M Cucunubá; Susy Echeverria Londono; Kaja Abbas; Hannah E Clapham; Mark Jit; Hope L Johnson; Timos Papadopoulos; Emilia Vynnycky; Marc Brisson; Emily D Carter; Andrew Clark; Margaret J de Villiers; Kirsten Eilertson; Matthew J Ferrari; Ivane Gamkrelidze; Katy A M Gaythorpe; Nicholas C Grassly; Timothy B Hallett; Wes Hinsley; Michael L Jackson; Kévin Jean; Andromachi Karachaliou; Petra Klepac; Justin Lessler; Xi Li; Sean M Moore; Shevanthi Nayagam; Duy Manh Nguyen; Homie Razavi; Devin Razavi-Shearer; Stephen Resch; Colin Sanderson; Steven Sweet; Stephen Sy; Yvonne Tam; Hira Tanvir; Quan Minh Tran; Caroline L Trotter; Shaun Truelove; Kevin van Zandvoort; Stéphane Verguet; Neff Walker; Amy Winter; Kim Woodruff; Neil M Ferguson; Tini Garske
Journal:  Lancet       Date:  2021-01-30       Impact factor: 79.321

8.  Emergence of multilateral proto-institutions in global health and new approaches to governance: analysis using path dependency and institutional theory.

Authors:  Eduardo J Gómez; Rifat Atun
Journal:  Global Health       Date:  2013-05-10       Impact factor: 4.185

9.  Maternal Supplementation with LGG Reduces Vaccine-Specific Immune Responses in Infants at High-Risk of Developing Allergic Disease.

Authors:  Paul V Licciardi; Intan H Ismail; Anne Balloch; Milton Mui; Edwin Hoe; Karen Lamb; Mimi L K Tang
Journal:  Front Immunol       Date:  2013-11-26       Impact factor: 7.561

10.  Innovative sources for funding of viral hepatitis prevention and treatment in low- and middle-income countries: a roundtable meeting report.

Authors:  David FitzSimons; Greet Hendrickx; Johannes Hallauer; Heidi Larson; Daniel Lavanchy; Ina Lodewyckx; Daniel Shouval; John Ward; Pierre Van Damme
Journal:  Hepatol Med Policy       Date:  2016-12-16
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.